04/23/19 Bridge Therapeutics Announces the Addition of Edward J. Minskoff to Its Board of Directors
Bridge Therapeutics is pleased to announce the addition of Edward J. Minskoff to its board of directors.
April 23, 2019
As a major Manhattan real estate acquirer and developer of 40 million square feet of commercial space, Edward J. Minskoff brings decades of financial and business experience to Bridge. On joining Bridge’s board, Mr. Minskoff commented, “I see Bridge improving the healthcare of millions as it becomes a highly successful pharmaceutical company.”